Sandoz Ambrisentan Tablets 5 mg (Ambrisentan TABLET) 5 MG

Sandoz Ambrisentan Tablets 5 MG are a pharmaceutical product used to manage specific health conditions. This oral medication is designed to support cardiovascular health and may be prescribed for related therapeutic uses.

Strength

5 MG

Manufacturer / TM Owner

SANDOZ CANADA INCORPORATED

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Ambrisentan is generally used to support cardiovascular health. It is often prescribed for conditions related to pulmonary arterial hypertension, helping to improve blood flow and reduce symptoms. Patients may wonder, 'What is Ambrisentan used for?' and it is typically utilized in the management of certain circulatory issues.

Side Effects

Common effects of Ambrisentan may include headaches, flushing, and peripheral edema. Some users might experience dizziness or nausea. These effects can vary among individuals and are not exhaustive. Always consult a healthcare provider for personalized advice.

Precautions & Warnings

Ambrisentan should be handled with care, especially for those with liver conditions or pregnant women. It is important to follow the guidance of a healthcare professional regarding its use. Proper storage and adherence to prescribed instructions are essential for safe usage.

Avoid Interactions

Ambrisentan may interact with certain medications, including CYP3A4 inhibitors and other cardiovascular drugs. Alcohol and other substances might also affect its efficacy. Always inform your healthcare provider about all medications you are taking to avoid potential interactions.

Frequently Asked Questions

Ambrisentan is typically used to support cardiovascular health, particularly in managing pulmonary arterial hypertension.

Store Ambrisentan tablets at room temperature, away from moisture and heat. Keep them out of reach of children.

Yes, dizziness is a common effect reported by some users of Ambrisentan. Always consult a healthcare provider if you experience severe dizziness.

Ambrisentan is not generally recommended for use during pregnancy. Consult a healthcare provider for personalized advice.

If you miss a dose, take it as soon as you remember. However, if it is almost time for your next dose, skip the missed dose and continue with your regular schedule.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.